Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: The INSPIRE study results

Authors
Category Primary study
JournalMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: f9f160624bea3cca84ce5eee9d4f5cccb5214510
First added on: Nov 20, 2025